A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia
Diabetic Medicine2017Vol. 35(4), pp. 483–490
Citations Over TimeTop 1% of 2017 papers
Abstract
CGM more effectively reduces time spent in hypoglycaemia in people with Type 1 diabetes and impaired awareness of hypoglycaemia compared with flash glucose monitoring. (Clinical Trial Registry No: NCT03028220).
Related Papers
- → Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System During Hypoglycemia(2004)112 cited
- → Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems(2020)35 cited
- → Continuous Glucose Monitor Shows Potential for Early Hypoglycemia Detection in Hospitalized Patients(2009)27 cited
- → Impact in real-world of intermittent-scanned continuous glucose monitoring with alarms on hypoglycemia and its recognition in type 1 diabetes(2024)2 cited
- → Continuous Glucose Monitoring Device for the Prevention of Severe Hypoglycemia(2008)